MAS A.Hepatic encephathy:from pathophysiology to treatment[J].Digestion,2006,73(1):86-93.
[2]
Romero-Gómez M,Jover M,Del Campo JA,et al.Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis:a cohort study[J].Ann Intern Med,2010,153(5):281-288.
[3]
Gunter KK,Aschner M,Miller LM,et al.Determining the oxidation states of manganesein NT2cells and cultured astrocytes[J].Neurobiol Aging,2006,27(2):1 816-1 826.
[4]
Jiang Q,Jiang XH,Zheng MH,et al.L-Ornithine-l-as partate in the management of hepatic encephalopathy:aetaanalysis[J].J Gastoenterol Hepatol,2009,24(1):9-14.
[5]
Albrecht J,Norenberg MD.Glutamine:a Trojanhorse in ammonia neurotoxicity[J].Hepatology,2006,44(4):788-794.
Shawcross DL,Sharifi Y,Canavan JB,et al.Infection and systemic inflammation,not ammonia,are associated with Grade 3/4hepatic encephalopathy,but not mortality in cirrhosis[J].J Hepatol,2011,54(4):640-649.
